EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents

Xiujuan Zhao, Ruikun Du iD, Lijun Rong

Pathogens · 10.09.2025 · 14 (9) · 911

DOI: 10.3390/pathogens14090911 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 10.09.2025. Verfasst von Xiujuan Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Heze University, Heze 274000, China. Hauptthemen laut MEDLINE: Antiviral Agents, Virus Diseases, Immune Tolerance, Host-Pathogen Interactions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heze University PhD Fund Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human immune system has evolved to cope with various virus infections using two major strategies: host defense and viral tolerance. The host defense relies on the innate and adaptive immune responses to control virus replication, while the viral tolerance allows sufficient virus replication in the host with minimal or no clinical signs. Generally, a balanced host defense and viral tolerance can guarantee health from infections, while disturbed immune homeostasis usually results in diseases. It is desirable to develop drugs/therapeutics to enhance the invulnerability of host immune equilibrium to combat viral infections. In this review, we summarize the advanced understanding on mechanisms of both the host defense against and tolerance to virus infections, and therapeutic agents/approaches that work by modulating the balance between host defense and tolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsVirus DiseasesImmune ToleranceHost-Pathogen InteractionsVirusesHumansImmunity, InnateAdaptive ImmunityVirus ReplicationAnimals

Stichwörter der Autor:innen

balancehost defensetherapeutic agentsviral tolerance

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • College of Pharmacy, Heze University, Heze 274000, China.
  • Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao 266122, China.
  • Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.

ORCID-Profile: Ruikun Du

Förderung

  • Heze University PhD Fund Planning

Zitieren

APA

Zhao, X., Du, R., & Rong, L. (2025). Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents. Pathogens, 14(9), 911. https://doi.org/10.3390/pathogens14090911

Vancouver

Zhao X, Du R, Rong L. Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents. Pathogens. 2025;14(9):911. doi:10.3390/pathogens14090911

BibTeX
@article{Zhao2025,
  author = {Zhao, Xiujuan and Du, Ruikun and Rong, Lijun},
  title = {Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {911},
  doi = {10.3390/pathogens14090911}
}
Kostenlos starten →